prednisone and Glomerulonephritis, Membranous studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.

Research Excerpts

Excerpt	Relevance	Reference
"The addition of prednisone after mizoribine monotherapy can be beneficial for all IMN patients with nephrotic-range proteinuria syndrome."	9.17	Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria. ( Matsumoto, Y; Moriki, T; Nojima, Y; Shimada, Y, 2013)
"Twenty-eight patients with an onset of nephrotic syndrome within 1 year were randomized to receive either ciclosporin and low-dose prednisone or high-dose prednisone alone."	9.07	A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children. ( Pomrantz, A; Suthanthiran, M; Tejani, A, 1991)
"The main adverse effects in TAC treatment were glucose intolerance, diabetes and abnormal aminotransferase."	6.84	The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy. ( Chen, J; Li, H; Li, X; Liang, Q; Qu, F; Xie, X, 2017)
"Tacrolimus has been used for idiopathic membranous nephropathy (IMN) therapy, but most patients who achieved remission showed a high relapse rate when tacrolimus was withdrawn after 6-12 months of therapy."	6.78	Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome. ( Jia, Y; Liu, N; Luo, P; Miao, LN; Sun, GD; Yuan, H, 2013)
"The treatment of membranous lupus nephritis (MLN) is still controversial in the literature."	5.37	Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis. ( Alves de Brito, G; Bitencourt Dias, C; Dos Santos Silva, V; Gera Abrão, J; Malafronte, P; Pinheiro, CC; Titan, S; Toledo Barros, R; Woronik, V, 2011)
"Both membranous glomerulopathy and acute interstitial nephritis have been reported to occur following treatment with non-steroidal anti-inflammatory drugs."	5.32	Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib. ( Appel, GB; D'Agati, VD; Falkowitz, DC; Imaizumi, S; Isom, R; Markowitz, GS; Zaki, M, 2003)
"The addition of prednisone after mizoribine monotherapy can be beneficial for all IMN patients with nephrotic-range proteinuria syndrome."	5.17	Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria. ( Matsumoto, Y; Moriki, T; Nojima, Y; Shimada, Y, 2013)
"This observational study aimed to evaluate the results of treatment with low-dose chlorambucil in combination with corticosteroids in patients with idiopathic membranous nephropathy (iMGN) and nephrotic syndrome."	5.14	Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy. ( Idasiak-Piechocka, I; Oko, A; Skrobańska, B; Łochyńska-Bielecka, K, 2009)
"We conducted a randomized trial in 51 biopsy-proven idiopathic MGN patients with nephrotic-range proteinuria comparing 26 weeks of cyclosporine treatment plus low-dose prednisone to placebo plus prednisone."	5.09	Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. ( Appel, GB; Cattran, DC; Hebert, LA; Hoy, WE; Hunsicker, LG; Kunis, CL; Maxwell, DR; Pohl, MA, 2001)
"Twenty-eight patients with an onset of nephrotic syndrome within 1 year were randomized to receive either ciclosporin and low-dose prednisone or high-dose prednisone alone."	5.07	A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children. ( Pomrantz, A; Suthanthiran, M; Tejani, A, 1991)
" It was found that RTX did not significantly improve serum albumin levels and e-GFR when compared with the control group (including cyclosporine and cyclophosphamide, chlorambucil, prednisone, non-immunosuppressive anti-proteinuria treatment), serum albumin levels (OR = 0."	5.05	Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis. ( Gong, S; Li, J; Lu, W; Luo, H; Wang, Y, 2020)
"Normally, Kimura disease-associated nephrotic syndrome patients are sensitive to prednisone therapy but are likely to relapse."	4.85	Kimura disease: a case report and review of the Chinese literature. ( Chen, YF; Gu, WZ; Liu, AM; Mao, JH; Wang, DY; Zhang, Y; Zhao, SA, 2009)
" Forty of them, who presented a nephrotic syndrome, were treated by immunosuppressive drugs (prednisone, azathioprine, chlorambucil, cyclophosphamide) for 79 +/- 9."	3.67	Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis. ( Glyda, J; Gradowska, L; Juskowa, J; Klepacka, J; Lao, M; Morzycka-Michalik, M; Orlowski, T; Rancewicz, Z, 1988)
"The main adverse effects in TAC treatment were glucose intolerance, diabetes and abnormal aminotransferase."	2.84	The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy. ( Chen, J; Li, H; Li, X; Liang, Q; Qu, F; Xie, X, 2017)
"Optimal treatment for pure membranous lupus nephritis (MLN) remains unknown."	2.82	Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population. ( Córdova-Sánchez, BM; Correa-Rotter, R; Mejía-Vilet, JM; Uribe-Uribe, NO, 2016)
"Tacrolimus has been used for idiopathic membranous nephropathy (IMN) therapy, but most patients who achieved remission showed a high relapse rate when tacrolimus was withdrawn after 6-12 months of therapy."	2.78	Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome. ( Jia, Y; Liu, N; Luo, P; Miao, LN; Sun, GD; Yuan, H, 2013)
"Patients with idiopathic membranous nephropathy (iMN) and renal insufficiency have a high risk for progression to end-stage renal disease (ESRD)."	2.71	Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate. ( Branten, AJ; du Buf-Vereijken, PW; Wetzels, JF, 2004)
"18 patients with membranous nephropathy, a nephrotic syndrome, and deteriorating renal function."	2.67	Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide. ( Assmann, K; Huysmans, FT; Koene, RA; Reichert, LJ; Wetzels, JF, 1994)
"Membranous nephropathy, focal segmental glomerulosclerosis (FSGS), and minimal change disease (MCD) are the most common causes of idiopathic nephrotic syndrome."	2.50	B cell suppression in primary glomerular disease. ( Deegens, JK; Hofstra, JM; Rood, IM; Wetzels, JF, 2014)
"Kidney biopsy showed membranous nephropathy."	2.41	Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case and review. ( Sakarcan, A; Stallworth, J, 2001)
"The treatment of idiopathic membranous glomerulopathy remains an enigma."	2.39	A review of therapeutic studies of idiopathic membranous glomerulopathy. ( Falk, RJ; Hogan, SL; Jennette, JC; Muller, KE, 1995)
"There is no definite treatment for focal glomerulosclerosis."	2.38	Treatment of the nephrotic syndrome with cyclosporin A. ( Ponticelli, C, 1992)
" Very long-term use of cyclophosphamide, in excess of 12 months, is probably associated with unacceptable long-term risks, particularly the emergence of neoplasia."	2.38	The therapy of idiopathic membranous glomerulonephritis. ( Glassock, RJ, 1991)
" Therefore, intravenous high-dose steroid pulses, alternate-day prednisone, short courses with cytotoxic agents and long-term administration of azathioprine have been suggested as alternatives to the classical prolonged corticotherapy."	2.38	Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults. ( Passerini, P; Ponticelli, C, 1991)
"To investigate the efficacy of cyclophosphamide combined with prednisone in membranous nephropathy (MN) patients with different cytochrome P450 (CYP) 2B6 gene polymorphisms and explore the factors influencing the efficacy."	1.72	The Efficacy of Cyclophosphamide Combined with Prednisone in Membranous Nephropathy Patients with Different Cytochrome P450 2B6 Gene Polymorphisms and Analysis of Factors Influencing the Efficacy. ( Liu, H; Lv, Y; Zhang, M, 2022)
"Key Words: PLA2R-associated idiopathic membranous nephropathy, Ponticelli regimen, Prednisone monotherapy."	1.72	The Efficacy of an Initial Prednisone Monotherapy Regimen on PLA2R-associated Idiopathic Membranous Nephropathy. ( Bai, Y; Diao, Z; Duan, Y; Liu, J; Liu, W, 2022)
"Rarely, it also occurs with membranous nephropathy (MN)."	1.62	Concurrent Anti-Glomerular Basement Membrane Antibody Disease and Membranous Nephropathy: A Case Series. ( Ahmad, SB; Ahn, W; Appel, GB; Bomback, AS; Canetta, P; D'Agati, VD; Markowitz, G; Radhakrishnan, J; Santoriello, D, 2021)
"The association between Takayasu's arteritis and membranous nephropathy is uncommon."	1.62	Takayasu's arteritis and secondary membranous nephropathy: an exceptional association. ( Enos, D; Hernandez, M; Labarca, G; Mendez, GP, 2021)
"Idiopathic Idiopathic membranous nephropathy (iMN) is an immune-complex mediated renal disease which is usually associated with the nephrotic syndrome (NS)."	1.56	Idiopathic Membranous Nephropathy and Treatment Related Complications. ( Dzemidzic, J; Haskovic, D; Muslimovic, A; Serdarevic, N; Uncanin, S, 2020)
"Membranous nephropathy is the most common glomerular lesion in IgG4- related kidney disease."	1.56	Idiopathic membranous nephropathy in a patient diagnosed with IgG4-related disease: A case report. ( Gedara, YSS; Ma, X; Sun, F; Sun, JY; Xu, H, 2020)
"In China, the prevalence of idiopathic membranous nephropathy (IMN) is increasing with a younger age of onset."	1.51	Efficacy and safety of tacrolimus-based treatment for nephrotic idiopathic membranous nephropathy in young adults: A retrospective study. ( Bai, DF; Fang, W; Hu, Z; Ji, CF; Wang, L; Yuan, JZ; Zhang, J; Zhang, XJ, 2019)
"Membranous nephropathy is a common cause of the nephrotic syndrome."	1.46	Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series. ( Cortazar, FB; Laliberte, K; Leaf, DE; Niles, JL; Owens, CT; Pendergraft, WF, 2017)
"We evaluated the efficacy and safety of tacrolimus (TAC) combined with corticosteroids in treating patients with idiopathic membranous nephropathy (IMN)."	1.46	Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy. ( Cui, W; Dong, W; Guan, S; Li, Q; Li, W; Liu, M; Lu, X; Luo, M; Luo, P; Miao, L; Min, X; Wang, Y, 2017)
"Gender, age, and hypertension are associated with KD recurrence."	1.43	Clinicopathological features and prognosis of Kimura's disease with renal involvement in Chinese patients. ( Chen, Y; Liu, Z; Wang, J; Xu, F; Zeng, C, 2016)
"The studies of idiopathic membranous nephropathy (IMN) require sufficiently long duration of follow-up to understand the effect of treatment on the development of end-stage renal disease (ESRD) in IMN."	1.42	A 10-year follow-up of idiopathic membranous nephropathy patients on steroids and cyclophosphamide: a case series. ( Guditi, S; Kaligotla Venkata, D; Ram, R, 2015)
"Treatment with prednisone or/and immunosuppressive drugs significantly reduced the frequency of CD4(+)CXCR5(+), CD4(+)CXCR5(+)PD-1(+) TFH cells and serum IL-21 level, but increased IL-4 and IL-10 levels in the patients."	1.40	Frequency of CD4+CXCR5+ TFH cells in patients with hepatitis b virus-associated membranous nephropathy. ( Ayana, DA; Jiang, Y; Liu, Y; Qu, Z; Zhao, P, 2014)
"FGN is a rare disease and may mimic membranous nephropathy under routine light microscopy and immunohistochemistry."	1.39	Fibrillary glomerulonephritis complicated by membranous nephropathy in a patient with tuberculosis. ( Ding, X; Liu, H; Liu, X; Zhang, Z; Zhao, Z, 2013)
"Treatment of idiopathic membranous nephropathy (IMN) remains a controversial issue."	1.39	Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety. ( Lu, W; Xie, L; Xue, W; Yang, S; Yin, A, 2013)
"Prednisone was initiated after making the diagnosis of ISD."	1.38	Membranous nephropathy: a rare renal manifestation of IgG4-related systemic disease. ( Bastacky, S; Craig, F; Jindal, N; Krasinskas, A; Liang, KV; Passero, C; Yadav, D, 2012)
"The treatment of membranous lupus nephritis (MLN) is still controversial in the literature."	1.37	Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis. ( Alves de Brito, G; Bitencourt Dias, C; Dos Santos Silva, V; Gera Abrão, J; Malafronte, P; Pinheiro, CC; Titan, S; Toledo Barros, R; Woronik, V, 2011)
"Idiopathic membranous nephropathy (IMN) is one of the most frequent causes of the nephrotic syndrome in adults and one of the most common cause of chronic renal failure among primary glomerular diseases."	1.36	Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy. ( Basta-Jovanovic, G; Furuncic, D; Jovanovic, D; Lezaic, V; Naumovic, R; Stosovic, M, 2010)
"Membranous nephropathy (MN) and polycystic kidney disease are both relatively rare diseases in children."	1.36	Idiopathic membranous nephropathy associated with polycystic kidney disease. ( Diomedi-Camassei, F; Emma, F; Kengne-Wafo, S; Massella, L, 2010)
"We studied the incidence of ESRD due to iMN in the Netherlands in the period 1991-2005."	1.35	Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands. ( Hofstra, JM; Wetzels, JF, 2008)
"Idiopathic membranous nephropathy (IMN) is one of the most common causes of primary nephrotic syndrome in adults."	1.34	Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome. ( Chandra, M; Chen, A; Crosby, V; Frank, R; Gauthier, B; Trachtman, H; Valderrama, E; Vento, S, 2007)
"We report a case of membranous nephropathy (MN) in a 12."	1.33	Membranous nephropathy associated with familial chronic ulcerative colitis in a 12-year-old girl. ( Gordjani, N; Gröne, HJ; Kiss, E; Kreth, HW; Ridder, RM, 2005)
"Both membranous glomerulopathy and acute interstitial nephritis have been reported to occur following treatment with non-steroidal anti-inflammatory drugs."	1.32	Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib. ( Appel, GB; D'Agati, VD; Falkowitz, DC; Imaizumi, S; Isom, R; Markowitz, GS; Zaki, M, 2003)
" The mean starting dosage of CsA was 4."	1.32	Cyclosporine A in treatment of membranous lupus nephropathy. ( Chen, H; Hu, W; Li, L; Li, S; Liu, Z; Shen, S; Yao, X, 2003)
"The association of membranous nephropathy with LCH might be attributable to an underlying abnormality in the immune system, a paraneoplastic manifestation, or both."	1.32	A case of Langerhans'-cell histiocytosis with membranous nephropathy. ( Cohen, E; Garty, M; Iaina, NL; Rachima, CM; Tobar, A, 2004)
"Hashimoto's thyroiditis and membranous nephropathy are believed to be mediated by immune mechanisms."	1.32	Autoimmune thyroiditis in association with membranous nephropathy. ( Bald, M; Hoyer, PF; Illies, F; Wingen, AM, 2004)
"We present a case of chronic lymphocytic leukemia associated with nephrotic syndrome."	1.32	Membranous glomerulonephritis in chronic lymphocytic leukemia. ( Giannouli, S; Nakopoulou, L; Psimenou, E; Voulgarelis, M; Ziakas, PD, 2004)
"Up to half of the patients with idiopathic membranous nephropathy (iMN) will develop renal failure."	1.31	Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group. ( Branten, AJ; Wetzels, JF, 2001)
"Primary membranous glomerulonephritis was diagnosed and immunosuppressive therapy was started."	1.31	Primary cerebral lymphoma and membranous nephropathy: a still unreported association. ( Maiorano, E; Manno, C; Occhiogrosso, G; Rossini, M; Schena, FP; Strippoli, GF, 2002)
"We report the case of a patient with acquired immunodeficiency syndrome (AIDS) who developed nephrotic syndrome and progressive renal failure mimicking human immunodeficiency virus (HIV)-associated focal segmental glomerulosclerosis (FSGS) who required initiation of hemodialysis and was found on renal biopsy to have membranous nephropathy."	1.30	AIDS-associated membranous nephropathy with advanced renal failure: response to prednisone. ( Ahuja, TS; Gooneratne, R; Mattana, J; Molho, L; Sankaran, RT; Schwarzwald, E; Siegal, FP; Singhal, PC, 1997)
"In primary minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS), increased lymphocyte reactivity to renal antigens has been defined."	1.30	Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response. ( Ahn, SJ; Bang, BK; Chang, YS; Choi, EJ; Kim, SY; Kim, YS; Park, CW; Shin, YS; Song, HC, 1998)
"Mean proteinuria was 9 g/day with a mean duration of disease of 25 months (range 12-48)."	1.30	A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy. ( Austin, HA; Balow, JE; Boumpas, DT; Fleisher, TA; Kim, Y; Piscitelli, S; Pucino, F; Tassiulas, IO; Vaughan, E, 1999)
"After treatment, all relapses remitted (third remission) in 3."	1.30	Relapsing membranous nephropathy. Response to therapy of relapses compared to that of the original disease. ( Frommer, JP; Suki, WN; Trimarchi, H, 1999)
"In this study three new cases of recurrence of membranous nephropathy are reported."	1.29	Membranous nephropathy: recurrence after kidney transplantation. ( Mampaso, F; Marcen, R; Navarro-Antolin, J; Orofino, L; Ortuño, J; Rivera, ME; Teruel, JL, 1996)
"We describe a patient with idiopathic membranous glomerulopathy who developed acute deterioration in renal function; this was associated with hemoptysis, severe hypertension, and anti-glomerular basement membrane (anti-GBM) antibody in the serum."	1.29	Goodpasture's syndrome superimposed on membranous nephropathy. A case report. ( Lal, SM; Luger, A; Ross, G; Thitiarchakul, S, 1995)
"It was difficult for WM in treating IgA nephropathy, membrano-proliferative GN and focal glomerulosclerosis, but Chinese medicinal herbs were effective with replenishing Qi and strengthening the Spleen, clearing away Dampness-Heat, promoting blood circulation and relieving Stasis, etc."	1.28	[Analysis of the treatment with traditional Chinese medicine in chronic glomerulonephritis based on histopathologic type]. ( Chen, YP; Hu, ZY; Zha, P, 1992)
"The significance of the finding of focal glomerulosclerosis (FGS) in idiopathic membranous glomerulonephritis (MGN) is uncertain."	1.28	Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. ( Magil, AB; Wakai, S, 1992)
"Nine of the controls reaching ESRD had persistent nephrotic syndrome, whereas of the seven controls who have not yet reached ESRD, only two have persistent nephrotic syndrome (chi 2, P less than 0."	1.28	Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function. ( Bear, R; Goldstein, M; Jindal, K; West, M, 1992)

Timeframe	Studies, this research(%)	All Research%
pre-1990	9 (8.18)	18.7374
1990's	35 (31.82)	18.2507
2000's	27 (24.55)	29.6817
2010's	29 (26.36)	24.3611
2020's	10 (9.09)	2.80

Trial			Phase	Enrollment	Study Type	Start Date	Status
Random, Open, Control and Monocentric Clinical Research on Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)[NCT03549663]				108 participants (Anticipated)	Interventional	2018-07-04	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Article	Year
Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis. Medicine, 2020, Volume: 99, Issue:16 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agen	2020
[Steroid and cyclosporine therapy in idiopathic membranous nephropathy: monocentric experience and literature review]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2019, Jun-11, Volume: 36, Issue:3 Topics: Adult; Aged; Cyclosporine; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosu	2019
B cell suppression in primary glomerular disease. Advances in chronic kidney disease, 2014, Volume: 21, Issue:2 Topics: Abatacept; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes;	2014
Kimura disease: a case report and review of the Chinese literature. Nephron. Clinical practice, 2009, Volume: 111, Issue:1 Topics: Adolescent; Adult; Angiolymphoid Hyperplasia with Eosinophilia; Biopsy; Child; Child, Preschool; Chi	2009
[Membranous nephropathy and crescentic glomerulonephritis]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2005, Volume: 25, Issue:3 Topics: Acute Kidney Injury; Adult; Cyclophosphamide; Female; Glomerulonephritis; Glomerulonephritis, Membra	2005
A review of therapeutic studies of idiopathic membranous glomerulopathy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1995, Volume: 25, Issue:6 Topics: Adolescent; Adult; Alkylating Agents; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Hum	1995
Efficacy of immunosuppressive treatment in patients with membranous nephropathy and renal insufficiency. Kidney international. Supplement, 1997, Volume: 61 Topics: Adult; Aged; Chlorambucil; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Immunosuppress	1997
Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case and review. Pediatric nephrology (Berlin, Germany), 2001, Volume: 16, Issue:8 Topics: Adolescent; Cyclophosphamide; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immun	2001
Treatment of the nephrotic syndrome with cyclosporin A. Journal of autoimmunity, 1992, Volume: 5 Suppl A Topics: Chlorambucil; Cyclophosphamide; Cyclosporine; Glomerulonephritis, Membranous; Glomerulosclerosis, Fo	1992
Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults. Clinical nephrology, 1991, Volume: 35 Suppl 1 Topics: Adult; Chlorambucil; Cyclophosphamide; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Seg	1991
The therapy of idiopathic membranous glomerulonephritis. Seminars in nephrology, 1991, Volume: 11, Issue:2 Topics: Alkylating Agents; Antineoplastic Agents; Glomerulonephritis, Membranous; Humans; Prednisolone; Pred	1991

Article	Year
Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy. Renal failure, 2020, Volume: 42, Issue:1 Topics: Adult; Autoantibodies; Biomarkers; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonep	2020
The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy. Renal failure, 2017, Volume: 39, Issue:1 Topics: Adult; Cyclophosphamide; Diabetes Mellitus; Drug Therapy, Combination; Female; Glomerular Filtration	2017
Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome. Pharmacology, 2013, Volume: 91, Issue:5-6 Topics: Adult; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive	2013
Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria. Renal failure, 2013, Volume: 35, Issue:7 Topics: Adult; Aged; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monito	2013
Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population. Clinical rheumatology, 2016, Volume: 35, Issue:9 Topics: Adolescent; Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephr	2016
Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy. Kidney & blood pressure research, 2009, Volume: 32, Issue:4 Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Female; Follow-Up	2009
Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:5 Topics: Adolescent; Adult; Aged; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up	2004
Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide. Annals of internal medicine, 1994, Sep-01, Volume: 121, Issue:5 Topics: Administration, Oral; Adult; Aged; Chlorambucil; Cyclophosphamide; Drug Administration Schedule; Dru	1994
Idiopathic membranous nephropathy in the elderly. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1993, Volume: 8, Issue:12 Topics: Adolescent; Adult; Aged; Chlorambucil; Creatinine; Drug Therapy, Combination; Female; Glomerulonephr	1993
Efficacy of immunosuppressive treatment in patients with membranous nephropathy and renal insufficiency. Kidney international. Supplement, 1997, Volume: 61 Topics: Adult; Aged; Chlorambucil; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Immunosuppress	1997
Effective treatment of idiopathic membranous nephropathy. Nephron, 2000, Volume: 86, Issue:4 Topics: Aged; Anti-Inflammatory Agents; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Mi	2000
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney international, 2001, Volume: 59, Issue:4 Topics: Adult; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; F	2001
A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children. Nephron, 1991, Volume: 59, Issue:1 Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Glomerulonephritis, Membranous; Glomerulosclerosi	1991
A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. The New England journal of medicine, 1989, Jan-26, Volume: 320, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Creatinine; Drug Administratio	1989
[Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. II. Membranous, membrano- proliferative and mesangial glomerulonephritis]. Przeglad lekarski, 1989, Volume: 46, Issue:12 Topics: Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Drug Therapy	1989

Article	Year
The Efficacy of an Initial Prednisone Monotherapy Regimen on PLA2R-associated Idiopathic Membranous Nephropathy. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2022, Volume: 32, Issue:3 Topics: Autoantibodies; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Prednisone; Recept	2022
The Efficacy of Cyclophosphamide Combined with Prednisone in Membranous Nephropathy Patients with Different Cytochrome P450 2B6 Gene Polymorphisms and Analysis of Factors Influencing the Efficacy. Drug design, development and therapy, 2022, Volume: 16 Topics: 8-Hydroxy-2'-Deoxyguanosine; Autoantibodies; Cyclophosphamide; Cytochrome P-450 CYP2B6; Glomerulonep	2022
Successful kidney transplantation after COVID-19. Transplant international : official journal of the European Society for Organ Transplantation, 2020, Volume: 33, Issue:10 Topics: Adult; Antibodies, Viral; Bacteremia; Basiliximab; Combined Modality Therapy; COVID-19; COVID-19 Tes	2020
Idiopathic Membranous Nephropathy and Treatment Related Complications. Medical archives (Sarajevo, Bosnia and Herzegovina), 2020, Volume: 74, Issue:3 Topics: Anti-Inflammatory Agents; Anticoagulants; Antineoplastic Agents, Alkylating; Chlorambucil; Drug Ther	2020
Idiopathic membranous nephropathy in a patient diagnosed with IgG4-related disease: A case report. Medicine, 2020, Oct-16, Volume: 99, Issue:42 Topics: Anti-Inflammatory Agents; Female; Glomerulonephritis, Membranous; Humans; Immunoglobulin G4-Related	2020
Concurrent Anti-Glomerular Basement Membrane Antibody Disease and Membranous Nephropathy: A Case Series. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021, Volume: 78, Issue:2 Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Glomerular Basement Membrane Disease; Auto	2021
Takayasu's arteritis and secondary membranous nephropathy: an exceptional association. BMJ case reports, 2021, Mar-01, Volume: 14, Issue:3 Topics: Cyclophosphamide; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Neoplasm Recurrence, Lo	2021
Characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with idiopathic membranous nephropathy. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:11 Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; China; Female; Glomerular Filtration Rate;	2021
Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2017, Mar-23, Volume: 50, Issue:4 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Creatinine; Cyclophosphamide; D	2017
Efficacy and safety of tacrolimus-based treatment for nephrotic idiopathic membranous nephropathy in young adults: A retrospective study. The Kaohsiung journal of medical sciences, 2019, Volume: 35, Issue:10 Topics: Adolescent; Adult; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immun	2019
Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety. Nephrology (Carlton, Vic.), 2013, Volume: 18, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Aged; Biopsy; China; Drug Therapy, Combination; Female; Glo	2013
Membranous glomerulonephritis in a patient with Hodgkin's lymphoma in remission. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Volume: 33, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D	2013
Leflunomide in idiopathic membranous nephropathy: a new immunosuppressive with promising treatment potential. Nephrology (Carlton, Vic.), 2014, Volume: 19, Issue:1 Topics: Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Isoxazole	2014
Frequency of CD4+CXCR5+ TFH cells in patients with hepatitis b virus-associated membranous nephropathy. International immunopharmacology, 2014, Volume: 22, Issue:1 Topics: Adult; CD4 Antigens; Cells, Cultured; Cytokines; Disease Progression; Female; Follow-Up Studies; Glo	2014
Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS. Clinical journal of the American Society of Nephrology : CJASN, 2014, Nov-07, Volume: 9, Issue:11 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Area Under Curve; Biomarkers; Female; Follow-Up Studies	2014
A 10-year follow-up of idiopathic membranous nephropathy patients on steroids and cyclophosphamide: a case series. Renal failure, 2015, Volume: 37, Issue:3 Topics: Adult; Cyclophosphamide; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Glom	2015
Clinicopathological features and prognosis of Kimura's disease with renal involvement in Chinese patients. Clinical nephrology, 2016, Volume: 85, Issue:6 Topics: Adolescent; Adult; Angiolymphoid Hyperplasia with Eosinophilia; Anti-Inflammatory Agents; China; Fem	2016
Clinical Predictors of Response to Prednisone Plus Cyclophosphamide in Patients with Idiopathic Membranous Nephropathy. Nephron, 2017, Volume: 135, Issue:2 Topics: Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Hu	2017
Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series. BMC nephrology, 2017, Feb-01, Volume: 18, Issue:1 Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Cyclophosphamide; Dose-Response Relationship,	2017
Membranous Glomerulopathy in Hypogammaglobulinemia. The American journal of the medical sciences, 2017, Volume: 353, Issue:3 Topics: Agammaglobulinemia; Chlorambucil; gamma-Globulins; Glomerulonephritis, Membranous; Humans; Infusions	2017
Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:11 Topics: Adult; Aged; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephritis, Me	2008
Idiopathic membranous nephropathy associated with polycystic kidney disease. Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:5 Topics: Biopsy; Child; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Hematuria; H	2010
Angioimmunoblastic T-cell lymphoma and membranous nephropathy: a still unreported association. Clinical and experimental nephrology, 2010, Volume: 14, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Glomerulonephritis, M	2010
Low-dose cyclosporine treatment in Chinese nephrotic patients with idiopathic membranous nephropathy: An uncontrolled study with prospective follow-up. The American journal of the medical sciences, 2010, Volume: 339, Issue:6 Topics: Adolescent; Adult; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomeruloneph	2010
Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2010, Volume: 64, Issue:9 Topics: Adult; Anti-Inflammatory Agents; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Female;	2010
Chronic periaortitis associated with membranous nephropathy: clues to common pathogenetic mechanisms. Clinical nephrology, 2010, Volume: 74, Issue:6 Topics: Aged; Biopsy; Chronic Disease; Fluorescent Antibody Technique; Genotype; Glomerulonephritis, Membran	2010
Treatment of nephrotic idiopathic membranous nephropathy with monthly i.v. pulse cyclophosphamide and oral steroids: a single centre's retrospective study. Nephrology (Carlton, Vic.), 2011, Volume: 16, Issue:4 Topics: Administration, Oral; Adult; Aged; Chi-Square Distribution; China; Cyclophosphamide; Drug Therapy, C	2011
Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis. Clinical nephrology, 2011, Volume: 76, Issue:1 Topics: Adult; Azathioprine; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephr	2011
Membranous nephropathy: a rare renal manifestation of IgG4-related systemic disease. Clinical nephrology, 2012, Volume: 77, Issue:4 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Biomarkers; Biopsy; Castleman Dis	2012
Membranous nephropathy with renal salt wasting: role of neurohumoral factors in sodium retention. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2012, Volume: 60, Issue:3 Topics: Blood Chemical Analysis; Creatinine; Cyclosporine; Disease Progression; Drug Therapy, Combination; E	2012
Membranous glomerulonephritis associated with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2012, Jul-17, Volume: 32, Issue:4 Topics: Acute Kidney Injury; Antibodies, Antineutrophil Cytoplasmic; Anticoagulants; Antihypertensive Agents	2012
Fibrillary glomerulonephritis complicated by membranous nephropathy in a patient with tuberculosis. International urology and nephrology, 2013, Volume: 45, Issue:5 Topics: Anti-Inflammatory Agents; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney G	2013
Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib. Clinical nephrology, 2003, Volume: 59, Issue:2 Topics: Acute Disease; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Fema	2003
MEMBRANOUS GLOMERULONEPHRITIS: DISCUSSION AND CASE PRESENTATION. The Journal of the American Osteopathic Association, 1964, Volume: 63 Topics: Adolescent; Adrenocorticotropic Hormone; Biopsy; Cortisone; Diagnosis; Electrons; Glomerulonephritis	1964
Cyclosporine A in treatment of membranous lupus nephropathy. Chinese medical journal, 2003, Volume: 116, Issue:12 Topics: Adolescent; Adult; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Lupus Nephritis; Ma	2003
A case of Langerhans'-cell histiocytosis with membranous nephropathy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2004, Volume: 43, Issue:2 Topics: Adult; Antineoplastic Agents; Glomerulonephritis, Membranous; Glucocorticoids; Histiocytosis, Langer	2004
Autoimmune thyroiditis in association with membranous nephropathy. Journal of pediatric endocrinology & metabolism : JPEM, 2004, Volume: 17, Issue:1 Topics: Child; Female; Glomerulonephritis, Membranous; Glucocorticoids; Growth Disorders; Humans; Low Densit	2004
Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:8 Topics: Adult; Aged; Cyclophosphamide; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immu	2004
[Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2004, Volume: 24 Suppl 3 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcineurin Inhibitors; Ca	2004
Membranous glomerulonephritis in chronic lymphocytic leukemia. American journal of hematology, 2004, Volume: 76, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biopsy; Cyclophosphamide; Glome	2004
Nephrotic syndrome in patients with peripheral blood stem cell transplant. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 45, Issue:4 Topics: Acute Kidney Injury; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineop	2005
Membranoproliferative glomerulonephritis type II in a 10-year-old girl. Clinical laboratory science : journal of the American Society for Medical Technology, 2005,Spring, Volume: 18, Issue:2 Topics: Child; Clinical Chemistry Tests; Diagnosis, Differential; Drug Therapy, Combination; Enalapril; Fema	2005
Membranous nephropathy associated with familial chronic ulcerative colitis in a 12-year-old girl. Pediatric nephrology (Berlin, Germany), 2005, Volume: 20, Issue:9 Topics: Azathioprine; Child; Colitis, Ulcerative; Female; Glomerulonephritis, Membranous; Humans; Immunosupp	2005
Systemic lupus erythematosus presenting with pancytopenia due to bone marrow myelofibrosis in a 22-year-old male. Clinical advances in hematology & oncology : H&O, 2004, Volume: 2, Issue:7 Topics: Adult; Bone Marrow; Epistaxis; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Lup	2004
Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation. Haematologica, 2005, Volume: 90 Suppl Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Asparagin	2005
Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome. BMC nephrology, 2007, Aug-06, Volume: 8 Topics: Adolescent; Biopsy; Child; Child, Preschool; Female; Glomerular Filtration Rate; Glomerulonephritis,	2007
Mesangiolytic glomerulopathy after radiotherapy and chemotherapy of gastric lymphoma. Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:22 Topics: Angiotensin II Type 1 Receptor Blockers; Antineoplastic Combined Chemotherapy Protocols; Combined Mo	2007
Mechanisms and management of nephrotic edema. Kidney international, 1994, Volume: 45, Issue:1 Topics: Edema; Glomerulonephritis, Membranous; Humans; Male; Methylprednisolone; Middle Aged; Prednisone	1994
Idiopathic membranous glomerulonephritis in the elderly. Contributions to nephrology, 1993, Volume: 105 Topics: Aged; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; K	1993
[Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide]. Vnitrni lekarstvi, 1993, Volume: 39, Issue:12 Topics: Adult; Chronic Disease; Cyclophosphamide; Drug Therapy, Combination; Glomerulonephritis, Membranopro	1993
Membranous nephropathy associated with nodular sclerosing Hodgkin's disease. Nephron, 1993, Volume: 63, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Glomerulonephritis, Membranous; Ho	1993
Membranous nephropathy with severe tubulointerstitial and vascular changes in a patient with psoriatic arthritis treated with non-steroidal anti-inflammatory drugs. Clinical nephrology, 1993, Volume: 39, Issue:5 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Biopsy; Female; Glomerulonephr	1993
Membranous nephropathy, interstitial nephritis, and Fanconi syndrome-- glomerular antigen. Pediatric nephrology (Berlin, Germany), 1996, Volume: 10, Issue:1 Topics: Anti-Inflammatory Agents; Antigens; Autoantibodies; Blotting, Western; Fanconi Syndrome; Fluorescent	1996
Membranous nephropathy: recurrence after kidney transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:6 Topics: Adult; Cyclosporine; Fluorescent Antibody Technique; Glomerulonephritis, Membranous; Humans; Kidney;	1996
Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy. Clinical nephrology, 1996, Volume: 45, Issue:6 Topics: Adult; Antineoplastic Agents, Alkylating; Chlorambucil; Follow-Up Studies; Glomerulonephritis, Membr	1996
Goodpasture's syndrome superimposed on membranous nephropathy. A case report. The International journal of artificial organs, 1995, Volume: 18, Issue:12 Topics: Anti-Glomerular Basement Membrane Disease; Anti-Inflammatory Agents; Antibodies; Basement Membrane;	1995
Mesenteric arterial thrombosis complicating the nephrotic syndrome. The New Zealand medical journal, 1997, Feb-28, Volume: 110, Issue:1038 Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Glomerulonephritis	1997
AIDS-associated membranous nephropathy with advanced renal failure: response to prednisone. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1997, Volume: 30, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Inflammatory Agents; Diagnosis, Differential; Female	1997
Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response. Nephron, 1998, Volume: 79, Issue:1 Topics: Adolescent; Adult; Biopsy; Creatinine; Diagnosis, Differential; Female; Glomerulonephritis, Membrano	1998
Disseminated cutaneous plasmacellular granuloma associated with membranous glomerulonephritis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:5 Topics: Anti-Inflammatory Agents; Child, Preschool; Glomerulonephritis, Membranous; Granuloma, Plasma Cell;	1999
Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:5 Topics: Anti-Inflammatory Agents; Chlorambucil; Drug Therapy, Combination; Glomerulonephritis, Membranous; H	1999
[Thin membrane nephropathy: 27 cases]. Zhonghua nei ke za zhi, 1997, Volume: 36, Issue:11 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Basement Membrane; Female; Glomerular Mesangium; Glomer	1997
Relapsing membranous nephropathy. Response to therapy of relapses compared to that of the original disease. American journal of nephrology, 1999, Volume: 19, Issue:4 Topics: Adult; Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Glomeru	1999
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy. Clinical nephrology, 1999, Volume: 52, Issue:2 Topics: Adult; Alkylating Agents; Anti-Inflammatory Agents; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-P	1999
Rhinocerebral mucormycosis in a patient with membranous glomerulonephritis. Nephron, 2000, Volume: 86, Issue:3 Topics: Eye; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Middle Aged; Mucormyc	2000
Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group. Clinical nephrology, 2001, Volume: 56, Issue:1 Topics: Administration, Oral; Analysis of Variance; Cyclophosphamide; Drug Therapy, Combination; Female; Glo	2001
Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy. Kidney international, 2002, Volume: 61, Issue:1 Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Creatinine;	2002
Hemiretinal vein occlusion associated with membranous glomerulonephritis. American journal of ophthalmology, 2002, Volume: 133, Issue:3 Topics: Adult; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Fundus Oculi; Glomeruloneph	2002
Primary cerebral lymphoma and membranous nephropathy: a still unreported association. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 39, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Female; Glo	2002
Delayed pubertal growth spurt in glomerulopathic boys receiving alternate-day prednisone. Child nephrology and urology, 1992, Volume: 12, Issue:4 Topics: Adolescent; Body Height; Body Weight; Child; Child, Preschool; Drug Administration Schedule; Female;	1992
[Analysis of the treatment with traditional Chinese medicine in chronic glomerulonephritis based on histopathologic type]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1992, Volume: 12, Issue:8 Topics: Adolescent; Adult; Biopsy, Needle; Child; Chronic Disease; Drugs, Chinese Herbal; Female; Glomerulon	1992
Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. Kidney international, 1992, Volume: 41, Issue:2 Topics: Acute Kidney Injury; Antihypertensive Agents; Cohort Studies; Female; Follow-Up Studies; Glomerulone	1992
Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1992, Volume: 19, Issue:1 Topics: Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephri	1992
Deep venous thrombosis in a child with nephrotic syndrome associated with a circulating anticoagulant and acquired protein S deficiency. The American journal of pediatric hematology/oncology, 1991,Fall, Volume: 13, Issue:3 Topics: Autoimmune Diseases; Carrier Proteins; Child; Complement Inactivator Proteins; Drug Eruptions; Drug	1991
Hepatitis C virus infection and membranous glomerulonephritis. Nephron, 1991, Volume: 59, Issue:2 Topics: Chlorambucil; Female; Glomerulonephritis, Membranous; Hepatitis Antibodies; Hepatitis C; Humans; Mal	1991
Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone. Annals of internal medicine, 1991, May-01, Volume: 114, Issue:9 Topics: Adult; Aged; Cholesterol; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulo	1991
Autoimmune enteropathy and nephropathy with circulating anti-epithelial cell antibodies. The Journal of pediatrics, 1991, Volume: 118, Issue:6 Topics: Atrophy; Autoantibodies; Autoimmune Diseases; Epithelial Cells; Epithelium; Glomerulonephritis, Memb	1991
Response to prednisone in membranous nephropathy associated with sarcoidosis. Nephron, 1990, Volume: 54, Issue:2 Topics: Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Prednisone; Sarcoidosis	1990
Retreatment of membranous nephropathy with steroids and chlorambucil after initial unresponsiveness to alternate-day prednisone. Clinical nephrology, 1990, Volume: 33, Issue:3 Topics: Chlorambucil; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Male; Middle Aged;	1990
[Clinical course in 51 patients with idiopathic membranous glomerulopathy]. Revista medica de Chile, 1989, Volume: 117, Issue:3 Topics: Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; M	1989
Immunosuppression for membranous nephropathy. Lancet (London, England), 1989, Jan-28, Volume: 1, Issue:8631 Topics: Adolescent; Adult; Chlorambucil; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up	1989
[The treatment of patients with idiopathic membranous glomerulonephritis with cyclosporin A]. Vutreshni bolesti, 1989, Volume: 28, Issue:4 Topics: Chronic Disease; Cyclophosphamide; Cyclosporins; Drug Evaluation; Drug Resistance; Glomerulonephriti	1989
Prednisone in the treatment of idiopathic membranous nephropathy. The New England journal of medicine, 1989, Jul-27, Volume: 321, Issue:4 Topics: Glomerulonephritis, Membranous; Humans; Prednisone	1989
What have we learned about the treatment of idiopathic membranous nephropathy with steroids? The New England journal of medicine, 1989, Jan-26, Volume: 320, Issue:4 Topics: Glomerulonephritis, Membranous; Humans; Prednisone	1989
Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis. Klinische Wochenschrift, 1988, Oct-17, Volume: 66, Issue:20 Topics: Adult; Azathioprine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up St	1988

prednisone and Glomerulonephritis, Membranous

Research Excerpts

Research

Studies (110)

Authors

Clinical Trials (1)

Trial Overview

Reviews

Trials

Other Studies

Authors	Studies
Bai, Y	1
Liu, J	1
Duan, Y	1
Liu, W	1
Diao, Z	1
Zhang, M	2
Lv, Y	1
Liu, H	2
Guo, Y	1
Wu, X	1
Liu, L	1
Zhang, H	1
Yang, L	2
Chen, W	1
Lu, W	2
Gong, S	1
Li, J	2
Luo, H	1
Wang, Y	2
Varotti, G	1
Dodi, F	1
Garibotto, G	1
Fontana, I	1
Uncanin, S	1
Dzemidzic, J	1
Serdarevic, N	1
Muslimovic, A	1
Haskovic, D	1
Ma, X	1
Xu, H	1
Sun, JY	1
Gedara, YSS	1
Sun, F	1
Ahmad, SB	1
Santoriello, D	1
Canetta, P	1
Bomback, AS	1
D'Agati, VD	2
Markowitz, G	1
Ahn, W	1
Radhakrishnan, J	1
Appel, GB	3
Enos, D	1
Labarca, G	1
Hernandez, M	1
Mendez, GP	1
Xia, P	1
Zhou, Y	1
Cui, Q	1
Chen, G	1
Zheng, K	1
Qin, Y	1
Li, X	2
Cui, W	1
Lu, X	1
Min, X	1
Liu, M	1
Guan, S	1
Luo, M	1
Li, W	1
Li, Q	1
Dong, W	1
Miao, L	1
Luo, P	2
Liang, Q	1
Li, H	1
Xie, X	1
Qu, F	1
Chen, J	1
Zhang, XJ	1
Ji, CF	1
Yuan, JZ	1
Wang, L	2
Zhang, J	1
Fang, W	3
Bai, DF	1
Hu, Z	1
Zotta, F	1
Di Stasio, E	1
Manzione, A	1
Pirozzi, N	1
Stoppacciaro, A	1
Menè, P	1
Yuan, H	1
Liu, N	1
Sun, GD	1
Jia, Y	1
Miao, LN	1
Matsumoto, Y	2
Shimada, Y	1
Nojima, Y	1
Moriki, T	1
Yang, S	1
Xie, L	1
Xue, W	1
Yin, A	1
Sánchez, M	1
Enríquez, R	1
Sirvent, AE	1
Heredia, L	1
Millán, I	1
Amorós, F	1
Chen, CL	1
Hsu, CY	1
Fang, HC	1
Rood, IM	1
Hofstra, JM	2
Deegens, JK	1
Wetzels, JF	7
Liu, Y	1
Zhao, P	1
Qu, Z	2
Ayana, DA	1
Jiang, Y	1
Li, F	1
Zheng, C	1
Zhong, Y	1
Zeng, C	2
Xu, F	2
Yin, R	1
Jiang, Q	1
Zhou, M	1
Liu, Z	3
Ram, R	1
Guditi, S	1
Kaligotla Venkata, D	1
Chen, Y	1
Wang, J	1
Mejía-Vilet, JM	1
Córdova-Sánchez, BM	1
Uribe-Uribe, NO	1
Correa-Rotter, R	1
Li, S	2
Zhou, W	1
Wang, Q	1
Qi, C	1
Mou, S	1
Shao, X	1
Ni, Z	2
Cortazar, FB	1
Leaf, DE	1
Owens, CT	1
Laliberte, K	1
Pendergraft, WF	1
Niles, JL	1
Schmidt, S	1
Sears, M	1
Crawford, S	1
Cicci, C	1
Diskin, CJ	1
Wang, DY	1
Mao, JH	1
Zhang, Y	2
Gu, WZ	1
Zhao, SA	1
Chen, YF	1
Liu, AM	1
Idasiak-Piechocka, I	1
Oko, A	1
Łochyńska-Bielecka, K	1
Skrobańska, B	1
Kengne-Wafo, S	1
Massella, L	1
Diomedi-Camassei, F	1
Emma, F	1
Togashi, M	1
Wakui, H	1
Kodama, K	1
Kameoka, Y	1
Komatsuda, A	1
Nimura, T	1
Ichinohasama, R	1
Sawada, K	1
Zhang, YM	1
Zhao, MH	1
Liu, G	1
Naumovic, R	1
Furuncic, D	1
Jovanovic, D	1
Stosovic, M	1
Basta-Jovanovic, G	1
Lezaic, V	1
Palmisano, A	1
Corradi, D	1
Carnevali, ML	1
Alberici, F	1
Silini, EM	1
Gatti, R	1
Allegri, L	1
Buzio, C	1
Vaglio, A	1
Yuan, J	1
Zhang, W	1
Qian, J	1
Bitencourt Dias, C	1
Pinheiro, CC	1
Malafronte, P	1
Titan, S	1
Alves de Brito, G	1
Gera Abrão, J	1
Dos Santos Silva, V	1
Toledo Barros, R	1
Woronik, V	1
Jindal, N	1
Yadav, D	1
Passero, C	1
Krasinskas, A	1
Craig, F	1
Bastacky, S	1
Liang, KV	1
Hommos, M	1
Sinkey, C	1
Haynes, WG	1
Dixon, BS	1
Zhou, GY	1
Liu, X	1
Zhao, Z	1
Zhang, Z	1
Ding, X	1
Markowitz, GS	1
Falkowitz, DC	1
Isom, R	1
Zaki, M	1
Imaizumi, S	1
LIEBERMAN, ME	1
Hu, W	1
Shen, S	1
Yao, X	1
Chen, H	1
Li, L	1
Rachima, CM	1
Cohen, E	1
Iaina, NL	1
Tobar, A	1
Garty, M	1
Illies, F	1
Wingen, AM	1
Bald, M	1
Hoyer, PF	1
du Buf-Vereijken, PW	2
Branten, AJ	2
Muñoz Díaz, AB	1
Aguilar, P	1
Ziakas, PD	1
Giannouli, S	1
Psimenou, E	1
Nakopoulou, L	1
Voulgarelis, M	1
Rao, PS	1
Tibbs, ME	1
Andreoli, SP	1
Phillips, CL	1
Ridder, RM	1
Kreth, HW	1
Kiss, E	1
Gröne, HJ	1
Gordjani, N	1
Vozmediano, C	1
Sánchez de la Nieta, MD	1
González, L	1
Alvarez, T	1
de la Torre, M	1
Blanco, J	1
Nieto, J	1
Rivera, F	1
Aziz, AR	1
Mohammadian, Y	1
Ruby, C	1
Momin, Z	1
Kumar, A	1
Griciene, P	1
Gintautas, J	1
Perrotta, S	1
Conte, ML	1
La Manna, A	1
Indolfi, P	1
Rossi, F	1
Locatelli, F	1
Nobili, B	1
Chen, A	1
Frank, R	1
Vento, S	1
Crosby, V	1
Chandra, M	1
Gauthier, B	1
Valderrama, E	1
Trachtman, H	1
Yoshimura, J	1
Kato, S	1
Tamaki, K	1
Kohno, K	1
Kaneyuki, U	1
Maeda, M	1
Saikusa-Itoh, Y	1
Hayashida, A	1
Iida, S	1
Suefuji, H	1
Okuda, S	1
Hogan, SL	1
Muller, KE	1
Jennette, JC	1
Falk, RJ	1
Reichert, LJ	2
Huysmans, FT	1
Assmann, K	1
Koene, RA	1
Humphreys, MH	1
Passerini, P	2
Como, G	1
Viganò, E	1
Melis, P	1
Pozzi, C	1
Altieri, P	1
Ponticelli, C	4
Bizzarri, D	1
Imperiali, P	1
Duranti, E	1
Sasdelli, M	1
Knotková, V	1
Nĕmecek, K	1
Tarayeva, IE	1
Krasnova, TN	1
Hotta, O	1
Taguma, Y	1
Kurosawa, K	1
Sudo, K	1
Takahashi, H	1
Grcevska, L	1
Polenaković, M	1
Ferluga, D	1
Vizjak, A	1
Stavrić, G	1
Makker, SP	1
Widstrom, R	1
Huang, J	1
Marcen, R	1
Mampaso, F	1
Teruel, JL	1
Rivera, ME	1
Orofino, L	1
Navarro-Antolin, J	1
Ortuño, J	1
Ardiles, LG	1
Mezzano, SA	1
Thitiarchakul, S	1
Lal, SM	1
Luger, A	1
Ross, G	1
McGregor, DO	1
Bailey, RR	1
Mattana, J	1
Siegal, FP	1
Schwarzwald, E	1
Molho, L	1
Sankaran, RT	1
Gooneratne, R	1
Ahuja, TS	1
Singhal, PC	1
Park, CW	1
Song, HC	1
Shin, YS	1
Ahn, SJ	1
Kim, YS	1
Kim, SY	1
Choi, EJ	1
Chang, YS	1
Bang, BK	1
Querfeld, U	1
Groth, W	1
Eder, EF	1
Hoppe, B	1
Sollberg, S	1
Moroni, G	1
Faricciotti, A	1
Farricciotti, A	1
Cappelletti, M	1
Zhou, R	1
Wang, S	1
Suki, WN	1
Trimarchi, H	1
Frommer, JP	1
Boumpas, DT	1
Tassiulas, IO	1
Fleisher, TA	1
Vaughan, E	1
Piscitelli, S	1
Kim, Y	1
Pucino, F	1
Balow, JE	1
Austin, HA	1
Akçay, A	1
Altun, B	1
Usalan, C	1
Güneş, D	1
Ulusoy, S	1
Kiykim, AA	1
Erdem, Y	1
Yasavul, U	1
Turgan, C	1
Caglar, S	1
Amano, I	1
Cattran, DC	2
Hebert, LA	1
Hunsicker, LG	1
Pohl, MA	1
Hoy, WE	1
Maxwell, DR	1
Kunis, CL	1
Sakarcan, A	1
Stallworth, J	1
Torres, A	1
Domínguez-Gil, B	1
Carreño, A	1
Hernández, E	1
Morales, E	1
Segura, J	1
González, E	1
Praga, M	1
Jorge, R	1
Scott, IU	1
Daré, A	1
Franco, RF	1
Flynn, HW	1
Strippoli, GF	1
Manno, C	1
Rossini, M	1
Occhiogrosso, G	1
Maiorano, E	1
Schena, FP	1
Polito, C	1
Di Toro, R	1
Hu, ZY	1
Chen, YP	1
Zha, P	1
Wakai, S	1
Magil, AB	1
Jindal, K	1
West, M	1
Bear, R	1
Goldstein, M	1
Garbrecht, F	1
Gardner, S	1
Johnson, V	1
Grabowski, E	1
Tejani, A	1
Suthanthiran, M	1
Pomrantz, A	1
Rollino, C	1
Roccatello, D	1
Giachino, O	1
Basolo, B	1
Piccoli, G	1
Bruns, FJ	1
Adler, S	1
Fraley, DS	1
Segel, DP	1
Glassock, RJ	1
Colletti, RB	1
Guillot, AP	1
Rosen, S	1
Bhan, AK	1
Hobson, CD	1
Collins, AB	1
Russell, GJ	1
Winter, HS	1
Oliver Rotellar, JA	1
García Ruiz, C	1
Martínez Vea, A	1
Tietjen, DP	1
Ardiles, L	1
Mezzano, S	1
Arriagada, A	1
Caorsi, I	1
Tishkov, I	1
Mushmov, D	1
Milkov, V	1
Lazarov, V	1
Rapundzhieva, A	1
Delmore, T	1
Roscoe, J	1
Cole, E	1
Cardella, C	1
Charron, R	1
Ritchie, S	1
Klinger, M	1
Szewczyk, Z	1
Relman, AS	1
Orlowski, T	1
Rancewicz, Z	1
Lao, M	1
Juskowa, J	1
Klepacka, J	1
Gradowska, L	1
Morzycka-Michalik, M	1
Glyda, J	1